Hepatitis C Symptoms and Screening – Types and Treatment
Mr. Bowers is a 35-year-old man who was recently diagnosed with asymptomatic hepatitis C. He has a history of injection drug use and was found to be infected with the hepatitis C virus on a routine annual visit. He is entirely asymptomatic and healthy otherwise. He wants to talk to his doctor regarding hepatitis C symptoms and screening and the advertisement he heard on the new medications for hepatitis C.
What is Hepatitis C (HCV)?
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). Hepatitis C is contagious and is usually transmitted through blood and less commonly via sexual intercourse (Centers for Disease Control and Prevention [CDC], 2025; World Health Organization [WHO], 2026). In the United States, an estimated 44,700 new hepatitis C infections occurred in 2017 (Schillie et al., 2020). Acute hepatitis C often causes few or no symptoms (CDC, 2025). Asymptomatic hepatitis C may be a slowly progressive liver disease. Most people who are infected develop chronic hepatitis C, which, left untreated, can cause severe liver damage (CDC, 2025). Most persons with chronic HCV infection do not experience symptoms, although they can develop cirrhosis and liver cancer.
Can Hepatitis C be cured?
Hepatitis C can be cured; understanding asymptomatic hepatitis C and screening is the first step. With the introduction of newer drugs, hepatitis C cure rates have increased to more than 95% (CDC, 2025; WHO, 2026). Doctors will check you, and if the virus is not detected in your blood 12 weeks after treatment ends, you are considered cured (Schillie et al., 2020). Read the article below for full information.
Asymptomatic Hepatitis C: Symptoms and Screening – What to Look For
Hepatitis C is a silent disease and is usually asymptomatic. Acute hepatitis C symptoms are typically mild and nonspecific, and when they do occur they usually appear 2–12 weeks after infection (CDC, 2025). The symptoms may include:
- flu-like symptoms
- fatigue
- poor appetite
- nausea
- mild right upper abdominal pain
- muscle and joint pain
- dark urine or clay-colored stools
- yellow skin or eyes (jaundice)
- or mild discomfort in the area of the liver.
Remember: asymptomatic hepatitis C and screening go together — you may not have any symptoms if you have a chronic HCV infection. Chronic infection often stays silent for decades until serious liver damage develops (WHO, 2026), and even people without symptoms can spread the virus to others through blood contact (CDC, 2025).
What Are Other Types of Hepatitis?
- Hepatitis A (usually from food or feces contaminated by infected individuals)
- Hepatitis B (from infected blood, sexual contact, or mother-to-baby transmission)
- Hepatitis D (from infected blood; it only affects people who already have hepatitis B)
- Hepatitis E (usually from contaminated food or water)
Who Should Be Tested for Hepatitis C?
Every patient 18 years or older needs to get a hepatitis C screening at least once (Schillie et al., 2020). The U.S. Preventive Services Task Force (USPSTF, 2020) likewise recommends one-time screening for adults aged 18 to 79. Regardless of age or environmental prevalence, patients with known exposures (such as injectable medications) should be screened for asymptomatic hepatitis C, and frequent testing should continue as long as risk factors persist (Schillie et al., 2020). We recommend hepatitis C screening in:
- Adults born from 1945 through 1965 (a higher-prevalence group, although all adults should now be screened)
- People who currently or formerly inject drugs (hepatitis C testing is advised even without symptoms)
- Individuals who received clotting components produced before 1987
- People who had organ transplants or blood transfusions before July 1992
- People with HIV infection, on hemodialysis, or someone with unknown liver disease
- People who have had a needle stick with HCV-positive blood
- Children born to a mother who is HCV-positive (infants are tested with an HCV RNA test from 2 months of age, or an antibody test at 18 months or later) (Schillie et al., 2020)
- Health care workers who are exposed to an accidental needle stick
How Is Hepatitis C Screened and Diagnosed?
Roughly 4 in 10 people with hepatitis C infection have never been told they have it, so asymptomatic hepatitis C and screening awareness matters (Schillie et al., 2020). Your doctor will request a hepatitis C blood test (an HCV antibody test) to check for infection. If it is positive, a follow-up HCV RNA test confirms whether the infection is active (CDC, 2025; WHO, 2026). If it is discovered that you have a chronic hepatitis C infection, your doctor may order additional tests to evaluate the severity of liver damage. Additional tests could include:
- Viral testing to detect HCV RNA (NAT-nucleic acid tests)
- Liver function tests (blood tests)
- Imaging studies (CT scan, MRI, or ultrasound)
- Liver biopsy (that involves taking a small sample of cells from the liver using a special needle) to help make decisions about treatment.
- Fibroscan: a noninvasive test to assess the degree of liver scarring and helps to guide treatment
What is The Treatment for Hepatitis C?
Recent new medications are approved in the market, causing fewer side effects, including Harvoni, Sovaldi, or Viekira Pak. Your doctor may recommend one or more of these more recent, direct-acting antiviral medications to treat hepatitis C. The hepatitis C treatment plan has reduced fatal and liver cirrhosis-related complications. Current guidance recommends treatment for nearly everyone with hepatitis C, except pregnant women and children under 3 (American Association for the Study of Liver Diseases [AASLD] & Infectious Diseases Society of America [IDSA], n.d.; CDC, 2025).
Talk to your doctor regarding getting ready for treatment. These treatments are better than previously available treatments as they don’t need to be injected and come in the form of a pill.
How long is hepatitis C treatment?
Most treatment regimens last for 8–12 weeks (CDC, 2025). Treatment may be extended to 24 weeks in the presence of advanced liver disease (cirrhosis) (WHO, 2026).
How Does Hepatitis C Spread?
Hepatitis C can spread when a person comes in contact with blood from an infected person (CDC, 2025). Injecting drugs is the most common route of hepatitis C transmission in the United States (Schillie et al., 2020). The best way to prevent HCV for people who inject drugs is to stop injecting. Community-based prevention programs, such as medication-assisted treatment and syringe services programs, can also reduce the transmission of HCV.
Q. Can you have hepatitis C without symptoms?
Yes. Hepatitis C is a silent disease and is usually asymptomatic, and most people with chronic HCV infection do not experience symptoms (CDC, 2025; WHO, 2026).
Q. Can you have hepatitis C and not know it?
Yes. Roughly 4 in 10 people with hepatitis C infection have never been told they have it, and testing is the only way to know (Schillie et al., 2020; CDC, 2025).
Q. Does sexual contact transmit Hepatitis C?
Although the risk of sexual transmission of HCV is considered low, avoiding unprotected sexual exposure by using condoms has been shown to reduce the chance of sexually transmitted infections. Less often, HCV transmission occurs through sexual contact with an HCV-infected partner, especially among people with multiple sex partners and men who have sex with men (WHO, 2026). So, they also need to undergo screening tests.
Q. Is there any vaccine available for Hepatitis C?
There is no vaccine to prevent hepatitis C. The best way to prevent HCV infection is to avoid contact with contaminated blood (CDC, 2025).
Q. Do sneezing, hugging, and kissing transmit the disease?
No. Hepatitis C is spread through blood-to-blood contact, not through sneezing, hugging, or kissing (CDC, 2025).
Q. Does the patient with Hepatitis C need to stay away from other healthy people?
No, you don’t have to stay away from healthy people. The virus is not spread through everyday interactions (CDC, 2025).
Advice for Patients with Hepatitis C
Key counseling points for people with hepatitis C include (Schillie et al., 2020):
- The efficiency and advantages of direct-acting antiviral medications
- The significance of abstaining from alcohol because it has been shown to hasten cirrhosis and end-stage liver disease
- The importance of maintaining an active lifestyle and eating a nutritious diet, particularly for patients who are overweight (defined as having a BMI of 25 kg/m2 or above) or obese (defined as having a BMI of 30 kg/m2)
- The significance of consulting a doctor before taking any new prescription medications, over-the-counter medications (such as pain medicines without aspirin), or vitamins because they may harm the liver.
- The requirement is to refrain from giving blood, tissue, or sperm.
- When exchanging personal things that might have blood on them, such as toothbrushes, dental tools, razors, nail clippers, and glucose meters, there is a minimal but present risk of transmission to sex partners.
- Hepatitis C cannot be spread by sneezing, hugging, holding hands, coughing, or sharing utensils, glasses, food, or water.
- Injuries and lesions on the skin must be covered to prevent the transmission of infectious blood or fluids.
Questions For Your Doctor?
- Can Hepatitis C be cured?
- Which treatment regimen is best for me?
- Do I have liver failure from Hepatitis C?
- What is the risk of sexual transmission of Hepatitis C?
- Can I drink alcohol?
Because hepatitis C is often silent, knowing asymptomatic hepatitis C and screening options helps you get tested early and start curative treatment.
References
American Association for the Study of Liver Diseases & Infectious Diseases Society of America. (n.d.). HCV guidance: Recommendations for testing, managing, and treating hepatitis C. Retrieved October 27, 2026, from https://www.hcvguidelines.org/
Centers for Disease Control and Prevention. (2025, September 2). Hepatitis C basics. https://www.cdc.gov/hepatitis-c/about/index.html
Schillie, S., Wester, C., Osborne, M., Wesolowski, L., & Ryerson, A. B. (2020). CDC recommendations for hepatitis C screening among adults—United States, 2020. MMWR Recommendations and Reports, 69(2), 1–17. https://doi.org/10.15585/mmwr.rr6902a1
U.S. Preventive Services Task Force. (2020, March 2). Hepatitis C virus infection in adolescents and adults: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
World Health Organization. (2026, July 28). Hepatitis C [Fact sheet]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
